Stock TARA PROTARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
2.925 USD -4.10% Intraday chart for Protara Therapeutics, Inc. +10.80% +55.99%
04-22 Oppenheimer Adjusts Protara Therapeutics Price Target to $30 From $26 MT
04-05 Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition CI

Chart calendar Protara Therapeutics, Inc.

f806cc9c5ad8a271.T4X-pu9LrGI0PTfW8X8j8lYFGpSY2qqMKWtuLTqDwPw.eta167wc4FFSV2W-q0hhuztqeN3hvcXLZBM8Zn62sap2_LCVqxrmLgBXWA~c1b03d9a346fef9800684e64082fc912

Upcoming events on Protara Therapeutics, Inc.

01/05/2024 Q1 2024 Earnings Release (Projected)
07/06/2024 17:00 Annual General Meeting
04/08/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Protara Therapeutics, Inc.

13/03/2024 12:00 Q4 2023 Earnings Release
06/03/2024 14:50 TD Cowen Health Care Conference - Fireside Chat
14/02/2024 13:40 Oppenheimer Healthcare Life Sciences Conference - Fireside Chat
07/02/2024 15:30 Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat
27/11/2023 Society of Urologic Oncology Meeting
03/11/2023 12:00 Q3 2023 Earnings Release
11/09/2023 14:30 H.C. Wainwright Global Investment Conference
03/08/2023 13:00 Q2 2023 Earnings Release
07/06/2023 17:00 Annual General Meeting
04/05/2023 13:00 Q1 2023 Earnings Release
14/03/2023 17:20 Oppenheimer Healthcare Conference
08/03/2023 14:50 Cowen Health Care Conference
08/03/2023 13:00 Q4 2022 Earnings Release
09/02/2023 16:20 Guggenheim Oncology Conference
02/12/2022 17:00 Society of Urologic Oncology Meeting - Poster No: 191
03/11/2022 12:00 Q3 2022 Earnings Release
12/09/2022 12:00 H.C. Wainwright Global Investment Conference
08/08/2022 13:00 Interim 2022 Earnings Release
08/06/2022 17:00 Annual General Meeting
04/06/2022 19:15 American Society of Clinical Oncology Meeting - Abstract No. TPS4620

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,2
-31,9
-7.36%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,83
-23,1
66.06%		-34,4
-34,2
-0.58%		-47,5
-53,4
11.02%		-37,5
-41,4
9.35%		-43,6
-44,8
2.72%
-54,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,0
-32,0
-6.32%		-47,3
-51,3
7.83%		-66,0
-37,5
-75.67%		-40,4
-42,2
4.33%
-50,9

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-34,0
-32,0
-6.32%		-47,3
-50,9
7.18%		-66,0
-37,3
-76.9%		-40,4
-41,8
3.35%
-50,6

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-4,70
-3,78
-24.34%		-4,21
-4,16
-1.12%		-5,86
-3,14
-86.82%		-3,57
-3,55
-0.49%
-3,21

Announcement Date11/03/2111/03/2109/03/2208/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,3
-14,0
26.32%		-10,9
-11,8
7.76%		-8,71
-12,2
28.8%		-7,97
-10,1
21.4%		-9,99
-9,99
-0.02%		-9,73
-11,6
16.38%		-12,1
-11,5
-6.02%		-10,7
-12,8
16.28%		-11,0
-12,2
9.54%
-12,0


-12,8


-13,3


-13,5




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-10,2
-14,2
28.15%		-10,8
-12,0
10%		-8,54
-12,7
32.53%		-7,69
-10,5
26.5%		-39,0
-10,6
-269.35%		-9,05
-12,1
25.4%		-11,3
-11,7
3.4%		-9,86
-12,3
19.84%		-10,2
-12,1
15.18%
-11,9


-12,7


-13,2


-13,2




Net income
Million USD		Released
Forecast
Spread 		-10,2
-13,9
26.3%		-10,8
-11,7
8.38%		-8,54
-12,2
30.25%		-7,69
-10,2
24.31%		-39,0
-9,92
-292.79%		-9,05
-11,6
22.17%		-11,3
-11,3
0.01%		-9,86
-12,4
20.36%		-10,2
-11,6
12.04%
-11,8


-12,6


-13,1


-13,2




EPS
USD		Released
Forecast
Spread 		-0,91
-0,94
3.53%		-0,96
-0,90
-6.27%		-0,80
-0,94
14.59%		-0,68
-0,76
10.13%		-3,46
-0,75
-361.33%		-0,80
-0,88
8.75%		-1,00
-0,88
-14.29%		-0,87
-0,98
11.22%		-0,90
-0,92
1.91%
-0,92


-0,80


-0,77


-0,78




Announcement Date09/03/2205/05/2209/08/2203/11/2208/03/2304/05/2303/08/2303/11/2313/03/24-----

Upcoming sector events for Protara Therapeutics, Inc.

28/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05 EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Protara Therapeutics, Inc.

25/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TARA Stock
  4. Calendar Protara Therapeutics, Inc.